Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.

Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement.
复制标题

疑似心脏受累的COVID-19患者CMR心肌损伤

DOI:
10.1016/j.jcmg.2022.10.021
复制
发表时间:
2023-05
影响因子:
14
通讯作者:
Han, Yuchi
Han, Yuchi
中科院分区:
医学1区
文献类型:
--
作者:
Vidula, Mahesh K.;Rajewska-Tabor, Justyna;Cao, J. Jane;Kang, Yu;Craft, Jason;Mei, Winifred;Chandrasekaran, Preethi S.;Clark, Daniel E.;Poenar, Ana-Maria;Gorecka, Miroslawa;Malahfji, Maan;Cowan, Eilidh;Kwan, Jennifer M.;Reinhardt, Samuel W.;Al-Tabatabaee, Sarah;Doeblin, Patrick;Villa, Adriana D. M.;Karagodin, Ilya;Alvi, Nazia;Christia, Panagiota;Spetko, Nicholas;Cassar, Mark Philip;Park, Christine;Nambiar, Lakshmi;Turgut, Alper;Azad, Mahan Roosta;Lambers, Moritz;Wong, Timothy C.;Salerno, Michael;Kim, Jiwon;Elliott, Michael;Raman, Betty;Neubauer, Stefan;Tsao, Connie W.;LaRocca, Gina;Patel, Amit R.;Chiribiri, Amedeo;Kelle, Sebastian;Baldassarre, Lauren A.;Shah, Dipan J.;Hughes, Sean G.;Tong, Matthew S.;Pyda, Malgorzata;Simonetti, Orlando P.;Plein, Sven;Han, Yuchi

文献摘要

参考文献

相似文献

对COVID-19和疑似心脏受累患者的心肌损伤尚不清楚。本研究的目的是描述一个多中心队列的COVID-19患者的心肌损伤特征,这些患者疑似心脏受累,转诊进行心脏磁共振(CMR)。这项回顾性研究包括来自18个国际研究中心的1,047名经聚合酶链反应证实的COVID-19感染并接受CMR的患者。心肌损伤的特点是急性心肌炎,非急性/非缺血,急性缺血,非急性/缺血模式的CMR。在该队列中,20.9%的患者具有非缺血性损伤模式(急性心肌炎:7.9%;非急性/非缺血性:13.0%),6.7%的患者具有缺血性损伤模式(急性缺血性:1.9%;非急性/缺血性:4.8%)。在单变量分析中,与急性心肌炎模式相关的变量包括胸部不适(OR:2.00; 95%CI:1.17-3.40,P = 0.01),心电图(ECG)异常(OR:1.90; 95%CI:1.12-3.23; P = 0.02),利钠肽升高(OR:2.99; 95% CI:1.60-5.58; P = 0.0006),肌钙蛋白升高(OR:4.21; 95% CI:2.41-7.36; P < 0.0001)。与急性缺血模式相关的变量包括胸部不适(OR:3.14; 95%CI:1.04-9.49; P = 0.04),ECG异常(OR:4.06; 95% CI:1.10-14.92; P = 0.04),已知冠心病(OR:33.30; 95%CI:4.04-274.53; P = 0.001),住院治疗(OR:4.98; 95%CI:1.55-16.05; P = 0.007),利钠肽升高(OR:4.19; 95% CI:1.30-13.51; P = 0.02),肌钙蛋白升高(OR:25.27; 95% CI:5.55-115.03; P < 0.0001)。在多变量分析中,肌钙蛋白升高与急性心肌炎模式密切相关(OR:4.98; 95%CI:1.76-14.05; P = 0.003)。在这项针对临床怀疑心脏受累转介CMR的COVID-19患者的多中心研究中,当出现心脏症状、ECG异常和心脏生物标志物升高时,非缺血性和缺血性模式很常见。
Myocardial injury in patients with COVID-19 and suspected cardiac involvement is not well understood. The purpose of this study was to characterize myocardial injury in a multicenter cohort of patients with COVID-19 and suspected cardiac involvement referred for cardiac magnetic resonance (CMR). This retrospective study consisted of 1,047 patients from 18 international sites with polymerase chain reaction–confirmed COVID-19 infection who underwent CMR. Myocardial injury was characterized as acute myocarditis, nonacute/nonischemic, acute ischemic, and nonacute/ischemic patterns on CMR. In this cohort, 20.9% of patients had nonischemic injury patterns (acute myocarditis: 7.9%; nonacute/nonischemic: 13.0%), and 6.7% of patients had ischemic injury patterns (acute ischemic: 1.9%; nonacute/ischemic: 4.8%). In a univariate analysis, variables associated with acute myocarditis patterns included chest discomfort (OR: 2.00; 95% CI: 1.17-3.40, P = 0.01), abnormal electrocardiogram (ECG) (OR: 1.90; 95% CI: 1.12-3.23; P = 0.02), natriuretic peptide elevation (OR: 2.99; 95% CI: 1.60-5.58; P = 0.0006), and troponin elevation (OR: 4.21; 95% CI: 2.41-7.36; P < 0.0001). Variables associated with acute ischemic patterns included chest discomfort (OR: 3.14; 95% CI: 1.04-9.49; P = 0.04), abnormal ECG (OR: 4.06; 95% CI: 1.10-14.92; P = 0.04), known coronary disease (OR: 33.30; 95% CI: 4.04-274.53; P = 0.001), hospitalization (OR: 4.98; 95% CI: 1.55-16.05; P = 0.007), natriuretic peptide elevation (OR: 4.19; 95% CI: 1.30-13.51; P = 0.02), and troponin elevation (OR: 25.27; 95% CI: 5.55-115.03; P < 0.0001). In a multivariate analysis, troponin elevation was strongly associated with acute myocarditis patterns (OR: 4.98; 95% CI: 1.76-14.05; P = 0.003). In this multicenter study of patients with COVID-19 with clinical suspicion for cardiac involvement referred for CMR, nonischemic and ischemic patterns were frequent when cardiac symptoms, ECG abnormalities, and cardiac biomarker elevations were present.
DOI: 10.1001/jamacardio.2020.3557
发表时间: 2020-11-01
期刊: JAMA CARDIOLOGY
影响因子: 24
作者:
Puntmann, Valentina O.;Carerj, M. Ludovica;Nagel, Eike
通讯作者: Nagel, Eike
DOI: 10.1002/ccd.28967
发表时间: 2020-05-29
影响因子: 2.3
作者:
Rothstein, Eric S.;Welch, Terrence D.;Jayne, John E.
通讯作者: Jayne, John E.
DOI: 10.1016/j.jcmg.2021.08.021
发表时间: 2022-04
期刊: JACC. Cardiovascular imaging
影响因子: --
作者:
Petersen SE;Friedrich MG;Leiner T;Elias MD;Ferreira VM;Fenski M;Flamm SD;Fogel M;Garg R;Halushka MK;Hays AG;Kawel-Boehm N;Kramer CM;Nagel E;Ntusi NAB;Ostenfeld E;Pennell DJ;Raisi-Estabragh Z;Reeder SB;Rochitte CE;Starekova J;Suchá D;Tao Q;Schulz-Menger J;Bluemke DA
通讯作者: Bluemke DA
DOI: 10.1093/ehjci/jeaa136
发表时间: 2020-07-01
影响因子: 6.2
作者:
Cosyns, Bernard;Lochy, Stijn;Edvardsen, Thor
通讯作者: Edvardsen, Thor
DOI: 10.1001/jamacardio.2020.1096
发表时间: 2020-07-01
期刊: JAMA CARDIOLOGY
影响因子: 24
作者:
Inciardi, Riccardo M.;Lupi, Laura;Metra, Marco
通讯作者: Metra, Marco